SF Insider Filing: Marischen Reports Sale and 31,171 Phantom Units
Rhea-AI Filing Summary
James M. Marischen, identified as Chief Financial Officer and a director/officer of Stifel Financial Corp. (SF), reported a sale of 5,000 shares of Stifel common stock on 08/19/2025 at a reported price of $112.90 per share. After that transaction the reporting person beneficially owned 63,846 shares directly. The filing also discloses 31,171 phantom stock units held beneficially, which vest in 20% increments over five years and have no expiration date. The Form 4 was signed on 08/22/2025. The filing contains only the transactions and unit vesting terms listed and no additional commentary or explanations.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider sale by the CFO; holdings remain material and long-term compensation consists of phantom units vesting over five years.
The Form 4 documents a single open-market sale of 5,000 common shares at $112.90 on 08/19/2025, reducing the reporting person's direct holdings to 63,846 shares. The presence of 31,171 phantom stock units, vesting at 20% per year over five years with no expiration, indicates a multi-year retention/compensation element. This disclosure is standard for executive compensation and insider trading reporting and contains no additional information about intent, plan transactions, or changes to compensation policies.
TL;DR: Disclosure is complete for the reported transactions; the phantom unit vesting schedule signals typical retention mechanics.
The filing clearly identifies the reporting person, relationship to the issuer, the date and price of the disposition, and the post-transaction beneficial ownership. The phantom stock units are disclosed with vesting and expiration details, satisfying common transparency expectations for executive equity compensation. There are no amendments, no 10b5-1 plan indication, and no other governance actions reported in this Form 4.
FAQ
What did Stifel (SF) CFO James Marischen report on Form 4?
How many phantom stock units does James Marischen hold per the filing?
Did the Form 4 indicate a 10b5-1 trading plan or amendment?
What is the reporting date and signature date on the Form 4?
Does the Form 4 disclose any other changes to compensation or governance?